Immune genes are exceptionally diverse among people, leading to individuals with different susceptibility towards protein drugs. Our therapeutics are precisely engineered to work despite each patient's unique immune profile and genetic background.
We develop technological platforms that deimmunize broad classes of therapeutics.
New functionalities. Advanced engineering. Our new gene-editing modalities constitute novel composition of matter.
We engineer immune-silent and immune-stealth therapeutics to benefit human lives. Gene-editing can cure the root causes of many human diseases. In making these therapeutics safer for patients, we are realizing our vision of a world without diseases.
